Navigating the landscape of final care and access to medications like Pentobarbital in New South Wales, Australia, requires a careful grasp of the complex legal structure. Currently, Pentobarbital does not have a recognized place on the Pharmaceutical Benefits Scheme (the scheme) and is therefore not commonly prescribed by clinical professionals. I